^
Association details:
Biomarker:IGF1 rs2016347
Cancer:Breast Cancer
Drug:tamoxifen (Estrogen receptor antagonist)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Source:
Title:

94P - Coexpression of PI3K/Akt signaling components and breast stem cells markers: Potential contributions in resistance to tamoxifen treatment

Published date:
09/14/2020
Excerpt:
Flow cytometry was used to evaluate the expression levels of CD326+CD44+CD24-/low, p-Akt473, PTEN, IGFR1 (CD221) and their combinations in fresh frozen breast cancer samples from 59 patients who developed distant metastasis....We observed higher frequency of G allele of IGFR1 rs2016347 among patients who did not benefit from tamoxifen treatment compare to tamoxifen sensitive patients (P=0.046).